Fate Therapeutics
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.21 | -100% | -21.83 | -100% |
| P/S |
|
5.3 | 33.44 | -84.16% |
|
|
| P/BV |
|
0.9135 | 4.65 | -80.34% |
|
|
| P/FCF |
|
-1.98 | 42.56 | -104.65% |
|
|
| Ev/Ebitda |
|
-2.5 | -17.68 | -85.86% |
|
|
| Ev/S |
|
6.27 | 22.52 | -72.17% |
|
|
| Ev/FCF |
|
-2.88 | 47.58 | -106.05% |
|
|
| E/P |
|
-0.5873 | 0.0188 | -3223.5% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-250.78 | -13.3 | 1785.59% | -322.77 | -22.3% |
| ROE |
|
-43.68 | 9.69 | -550.77% |
|
|
| ROA |
|
-31.79 | 0.2896 | -11077.17% |
|
|
| ROIC |
|
-28.41 | 7.63 | -472.13% |
|
|
| ROS |
|
-253.3 | -25.08 | 910.12% |
|
|
| ROCE |
|
-48.21 | 14.58 | -430.77% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.6498 | -3.62 | -82.06% | -0.5657 | +14.87% |
| Nеt Debt/Ebitda |
|
-0.387 | -4.05 | -90.45% |
|
|
| Debt/Ratio |
|
0.2045 | 0.1841 | 11.07% |
|
|
| Debt/Equity |
|
0.2062 | 1.6 | -87.08% |
|
|
| Debt/Net Income |
|
-0.6434 | 0.9168 | -170.18% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
493.77 | 31.71 | 1457.14% | ||
| Growth impulse Ebitda in 5 years |
|
78.66 | -23.28 | -437.89% | ||
| Growth impulse Net Income in 5 years |
|
67.63 | -61.56 | -209.86% | ||
| Growth impulse FCF in 5 years |
|
52.78 | -26 | -303% | ||
| Growth impulse EPS in 5 years |
|
15.98 | -63.63 | -125.11% |
IP Score
4.47/10
